CUV
Click for more information
0.07% $15.25 clinuvel pharmaceuticals limited

Ann: CLINUVEL Extends CEO Employment Agreement

  1. ASX News
    lightbulb Created with Sketch. 851
    clock Created with Sketch.
    01/04/22
    09:57
    Post #: 60569321
    Likes Created with Sketch.  Upvote
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

BIO Biome posts record sales revenue of $13M in FY24 – up 80% vs pcp and higher than forecast
right-arrow Created with Sketch.
NEWS Has uranium run out of steam? An update on nuclear markets & developments ahead in FY25
right-arrow Created with Sketch.
AHK Ark Mines defines significant exploration target at Sandy Mitchell rare earths project
right-arrow Created with Sketch.
EX1 Tryptamine Therapeutics completes maiden dosing of IV psilocin – a global first
right-arrow Created with Sketch.
EMD Emyria and UWA secure $499,411 grant to advance MDMA analogue drug program
right-arrow Created with Sketch.
LRV Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%
right-arrow Created with Sketch.
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
(20min delay)
Last
$15.25 		Change
-0.010(0.07%) 		Mkt cap ! $764.0M
Open High Low Value Volume
$15.25 $15.32 $15.22 $415.5K 27.24K

Buyers (Bids)

No. Vol. Price($)
4 459 $15.22
 

Sellers (Offers)

Price($) Vol. No.
$15.30 630 1
View Market Depth
Last trade - 16.10pm 03/07/2024 (20 minute delay) ?
CUV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.